Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

EKF Launches POC Lactate Analyzer with Hematocrit Compensation

Published: Wednesday, December 04, 2013
Last Updated: Wednesday, December 04, 2013
Bookmark and Share
Built-in hematocrit compensation delivers high accuracy lactate analysis.

EKF Diagnostics announces the launch of the new version of its Lactate Scout+ analyzer. Initially developed to provide coaches and athletes with a precise and easy-to-use mobile lactate test, Lactate Scout’s additional features and functionality – including hematocrit compensation – now mean the device can be used in new medical applications.

The in-built compensation for hematocrit (Hct) within Lactate Scout+ ensures accurate lactate measurements even at high (>50%) or low (<35%) Hct levels. The new analyzer’s Hct range is 20-70%, which means patients with either very low Hct levels (e.g. after blood loss) or very high levels (e.g. professional athletes and neonates) can be accurately assessed. This makes Lactate Scout+ ideal for a range of medical applications. These include cardio training, weight reduction and fitness applications which are already well established, as well as new applications in obstetrics.

As a world-leader in lactate, EKF has been closely involved in research projects investigating applications of lactate in obstetric medicine. For example, cord blood lactate (CBL) analysis can give a picture of acid-base balance at birth and is particularly recommended after high risk deliveries. Fetal scalp lactate (FSL) can be used to confirm abnormal cardiotocography values and the need for immediate intervention in complicated births where there may be risk of insufficient fetal oxygen supply.

EKF CEO, Julian Baines commented, “The launch of the new version of Lactate Scout+ reaffirms EKF Diagnostics’ long term expertise in lactate measurement. We are a well-established manufacturer, supplier, distributor and exporter globally of lactate analyzers delivering dependable pre- and post-sale support. We also pride ourselves on developing easy-to-use devices that provide reliable, fast and accurate results.”

About Lactate Scout+
•    Results within 10 seconds
•    0.2 µL finger prick or earlobe sample
•    Hematocrit compensation
•    Integrated Bluetooth connectivity for data download
Stores up to 250 results


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

EKF Molecular Diagnostics Collaborates with ANGLE
Combined technologies may identify all mutations in gene sequences associated with clinical utility of targeted cancer therapies.
Thursday, January 29, 2015
EKF Molecular and Massachusetts General Hospital Collaborate
Research collaboration to confirm clinical utility of PointMan™ and CTC-iChip technologies for non-invasive cancer diagnosis and monitoring.
Tuesday, September 23, 2014
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!